SLC25A45 Antibody

What is SLC25A45 and why is it significant for mitochondrial research?

SLC25A45 (solute carrier family 25 member 45) is a 288 amino acid multi-pass membrane protein that facilitates metabolite transport across the inner mitochondrial membrane . Its significance lies in maintaining cellular energy metabolism by ensuring essential substrates are available for mitochondrial respiration and ATP production . As a member of the mitochondrial carrier family (TC 2.A.29), it contains three characteristic Solcar repeats and is expressed in various tissues . When designing experiments to investigate mitochondrial transport mechanisms, SLC25A45 serves as an important model protein due to its involvement in fundamental metabolic processes.

Research methodology should incorporate:

• Mitochondrial isolation protocols before protein extraction

• Membrane fraction enrichment techniques

• Careful selection of detergents for solubilization

• Control comparisons with other SLC25 family members

What are the validated applications for SLC25A45 antibodies in basic research?

SLC25A45 antibodies have been validated for multiple applications essential for basic characterization studies. The primary validated applications include Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Enzyme-linked immunosorbent assay (ELISA), and Immunoprecipitation (IP) . For researchers new to working with this protein, a methodological approach would begin with Western Blotting to confirm antibody specificity, followed by localization studies using immunofluorescence or immunohistochemistry.

How do I select the appropriate SLC25A45 antibody for my experimental model?

When selecting an SLC25A45 antibody, researchers should consider species cross-reactivity, epitope location, and experimental application compatibility. Available antibodies demonstrate varying reactivity profiles, with some recognizing human, mouse, rat, rabbit, cow, guinea pig, and horse SLC25A45 proteins . The selection process should begin with sequence alignment analysis of your experimental model's SLC25A45 against the immunogen sequence.

Methodological approach:

• Perform BLAST analysis of the target species' SLC25A45 sequence against human reference

• Prioritize antibodies with demonstrated reactivity in your model organism

• Consider epitope location (C-terminal antibodies show broad reactivity patterns )

• Review available validation data for your specific application

• Begin with antibodies having published citations when available

How can SLC25A45 antibodies be utilized to investigate isoform-specific functions?

SLC25A45 produces four known isoforms through alternative splicing, exhibiting potentially diverse functional roles in different biological contexts . Investigating isoform-specific functions requires careful antibody selection and experimental design. The methodological approach should include:

• Epitope mapping analysis to determine which isoforms each antibody recognizes

• Using antibodies targeting regions common to all isoforms for total SLC25A45 detection

• Employing isoform-specific antibodies when available, or combining with RNA analysis methods

• Implementing control experiments with recombinant isoform proteins

Researchers should consider that antibodies raised against the C-terminal region may not detect all isoforms if alternative splicing affects this region . Complementing antibody-based approaches with mRNA expression analysis can provide comprehensive isoform characterization.

What methodologies are available for studying SLC25A45's role in mitochondrial transport mechanisms?

Investigating SLC25A45's transport function requires specialized approaches beyond basic protein detection. Advanced methodological strategies include:

• Mitochondrial isolation and transport assays:

  • Prepare purified mitochondria from tissues or cells expressing SLC25A45

  • Measure substrate uptake in the presence of SLC25A45 antibodies or after SLC25A45 knockdown

  • Compare transport kinetics with reconstituted liposomes containing purified SLC25A45

• Proximity labeling techniques:

  • Employ BioID or APEX2 fusion constructs with SLC25A45 to identify interacting proteins

  • Use antibodies to confirm interactions via co-immunoprecipitation

  • Validate transport substrates through metabolomics analysis

• Live-cell imaging approaches:

  • Utilize fluorescent substrate analogs combined with SLC25A45 immunofluorescence

  • Employ FRET-based sensors for real-time transport activity monitoring

These methodologies help elucidate the specific metabolites transported by SLC25A45 and its regulatory mechanisms in maintaining mitochondrial homeostasis.

How can I investigate SLC25A45's potential association with diseases linked to chromosome 11 abnormalities?

The human gene encoding SLC25A45 is located on chromosome 11, a region associated with several diseases including Wilms' tumors and WAGR syndrome . Investigating these associations requires sophisticated experimental approaches:

• Tissue-specific expression analysis:

  • Compare SLC25A45 expression levels between normal and pathological samples using antibody-based techniques (IHC, IF, WB)

  • Quantify expression differences using standardized protocols and appropriate controls

  • Correlate expression with clinical parameters and genetic alterations

• Functional studies in disease models:

  • Use SLC25A45 antibodies in combination with disease markers

  • Perform co-localization studies in affected tissues

  • Investigate mitochondrial dysfunction parameters in correlation with SLC25A45 alterations

• Genetic association analysis:

  • Examine SLC25A45 genetic variations in patient cohorts

  • Correlate findings with protein expression using antibody-based quantification

  • Implement functional validation of variants using recombinant expression systems

What are the critical validation steps for confirming SLC25A45 antibody specificity?

Ensuring antibody specificity is paramount for obtaining reliable data. A comprehensive validation workflow should include:

• Western blot validation:

  • Positive controls (tissues with known SLC25A45 expression)

  • Negative controls (SLC25A45 knockout or knockdown samples)

  • Blocking peptide competition assays using neutralizing peptides

  • Molecular weight verification (~32 kDa for canonical isoform)

• Immunohistochemistry validation:

  • Comparison across multiple antibody clones or sources

  • Correlation with mRNA expression data

  • Subcellular localization confirmation (mitochondrial pattern)

  • Absorption controls with immunizing peptide

• Specificity across applications:

  • Consistent results across multiple detection methods

  • Cross-validation with orthogonal techniques (mass spectrometry)

What are the recommended protocols for SLC25A45 immunohistochemistry in various tissue types?

For optimal immunohistochemical detection of SLC25A45 across tissue types, researchers should consider these methodological recommendations:

• Paraffin-embedded section protocol:

  • Heat-induced epitope retrieval (HIER) in citrate buffer (pH 6.0)

  • Blocking in 5-10% normal serum from secondary antibody host species

  • Primary antibody incubation at 4°C overnight (1:100-1:500 dilution)

  • Detection with polymer or avidin-biotin systems

  • Counterstaining with hematoxylin for nuclear contrast

• Frozen section protocol modifications:

  • Fixation in cold acetone (10 minutes)

  • Shorter primary antibody incubation times (1-2 hours at room temperature)

  • More dilute antibody concentrations (1:200-1:1000)

• Tissue-specific considerations:

  • Higher antibody concentrations may be needed for tissues with lower expression

  • Double staining with mitochondrial markers for co-localization studies

  • Autofluorescence reduction steps for tissues like brain or liver

How should researchers optimize Western blot protocols for SLC25A45 detection?

Optimizing Western blot protocols for SLC25A45 requires attention to several technical aspects:

• Sample preparation:

  • Include protease inhibitors to prevent degradation

  • Consider mitochondrial enrichment protocols for enhanced detection

  • Use appropriate lysis buffers for membrane protein solubilization (containing 0.5-1% NP-40 or Triton X-100)

• Electrophoresis and transfer conditions:

  • 10-12% SDS-PAGE gels recommended

  • Transfer using wet systems for optimal membrane protein transfer

  • PVDF membranes preferred over nitrocellulose for hydrophobic proteins

• Detection optimization:

  • Primary antibody concentration: 5 μg/mL (approximately 1:200 dilution)

  • Extended primary antibody incubation (overnight at 4°C)

  • Enhanced chemiluminescence detection systems for optimal sensitivity

How can researchers address non-specific binding issues with SLC25A45 antibodies?

Non-specific binding can complicate data interpretation. Methodological approaches to resolve these issues include:

• Blocking optimization:

  • Extend blocking time (2-3 hours at room temperature)

  • Test alternative blocking agents (5% milk, 5% BSA, or commercial blocking buffers)

  • Include 0.1-0.3% Triton X-100 in blocking buffer for better penetration

• Antibody dilution and incubation adjustments:

  • Increase antibody dilution incrementally (1:500, 1:1000, 1:2000)

  • Add low concentrations of detergent (0.05% Tween-20) to antibody diluent

  • Incorporate 5% normal serum from host species into antibody diluent

• Validation controls:

  • Always include neutralizing peptide competition controls

  • Use SLC25A45 knockout or knockdown samples as negative controls

  • Consider using multiple antibodies targeting different epitopes

What approaches can be used to quantitatively analyze SLC25A45 expression across different experimental conditions?

Quantitative analysis of SLC25A45 requires standardized approaches:

• Western blot quantification:

  • Use housekeeping proteins or total protein staining (Ponceau S) for normalization

  • Employ mitochondrial markers (VDAC, COX IV) for specific comparisons

  • Utilize digital imaging systems with linear dynamic range

  • Apply appropriate statistical analyses for multiple sample comparisons

• Immunohistochemistry quantification:

  • Establish standardized scoring systems (H-score, Allred score)

  • Utilize digital image analysis software for objective quantification

  • Compare relative staining intensity across experimental groups

  • Include internal control tissues in each staining batch

• Flow cytometry approaches:

  • Permeabilize cells for intracellular SLC25A45 detection

  • Use median fluorescence intensity for quantitative comparisons

  • Include isotype controls and unstained samples

  • Normalize to mitochondrial mass markers for accurate interpretation

How should researchers interpret contradictory results between different SLC25A45 antibodies?

When facing contradictory results between different SLC25A45 antibodies, a systematic analytical approach is required:

• Epitope analysis:

  • Compare the epitope regions targeted by each antibody

  • Determine if epitope accessibility might differ in various applications

  • Consider potential isoform-specific recognition patterns

• Validation comparison:

  • Evaluate the validation data available for each antibody

  • Prioritize results from antibodies with more extensive validation

  • Consider antibody format differences (monoclonal vs. polyclonal)

• Resolution strategies:

  • Use orthogonal techniques for independent verification

  • Perform genetic knockdown/knockout experiments

  • Consider advanced techniques like mass spectrometry for protein identification

  • Consult published literature for similar discrepancies and resolutions

What emerging techniques could enhance SLC25A45 functional characterization using antibody-based approaches?

Several cutting-edge methodologies hold promise for advancing SLC25A45 research:

• Advanced imaging approaches:

  • Super-resolution microscopy for detailed mitochondrial localization

  • Live-cell imaging with fluorescently tagged antibody fragments

  • Correlative light and electron microscopy for ultrastructural analysis

• High-throughput screening applications:

  • Antibody arrays for expression profiling across tissues and conditions

  • Automated immunohistochemistry for large-scale tissue analysis

  • CRISPR screening combined with antibody detection for functional networks

• Single-cell analysis:

  • Mass cytometry (CyTOF) with metal-conjugated antibodies

  • Single-cell Western blotting techniques

  • In situ proximity ligation assays for protein-protein interaction studies

These emerging techniques, when combined with established antibody applications, will significantly expand our understanding of SLC25A45's role in cellular metabolism and disease.